Community Health Systems Sells Laboratory Assets to Labcorp for $194 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 02 2025
0mins
Source: Newsfilter
- Transaction Completion: Community Health Systems' subsidiary CHS has successfully sold select ambulatory outreach laboratory service assets in 13 states to Labcorp for approximately $194 million in cash, enhancing patient and provider access to high-quality laboratory services.
- Service Focus: This transaction allows Community Health Systems to concentrate on core services, improving the overall patient experience and reinforcing its commitment to providing high-quality healthcare.
- Technological Support: Labcorp's scale and investment in technology will enable efficient delivery of outreach laboratory services, thereby improving patient care and driving efficiencies for customers, aligning with both companies' shared commitment to enhancing community health.
- Strategic Relationships: This transaction is part of Labcorp's strategy to establish relationships with various health systems, aimed at increasing access to laboratory services, improving patient care, and driving efficiencies for customers.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CYH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CYH
Wall Street analysts forecast CYH stock price to rise
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 2.770
Low
2.00
Averages
3.67
High
5.00
Current: 2.770
Low
2.00
Averages
3.67
High
5.00
About CYH
Community Health Systems, Inc. is a healthcare company. The Company’s affiliates are providers of healthcare services, developing and operating healthcare delivery systems in approximately 33 distinct markets across 13 states. Its subsidiaries own or lease 64 affiliated hospitals with more than 9,000 beds and operate more than 900 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. It provides a range of general and specialized hospital healthcare services and outpatient services. Services provided through its hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is its network of affiliated physicians at its hospitals and affiliated businesses.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Conference Participation: Community Health Systems will participate in the RBC Capital Markets Global Healthcare Conference on May 19-20, 2026, in New York, hosting a fireside chat presentation on May 20 at 9 a.m. ET, showcasing its strategic direction in healthcare services.
- Investor Engagement: The fireside chat will be available via a live audio webcast on the company's investor relations website, enhancing interaction and transparency between the company and its investors through accessible communication.
- Company Overview: Community Health Systems is one of the largest healthcare companies in the U.S., operating in 33 markets across 13 states, owning or leasing 64 hospitals and over 900 care sites, demonstrating its extensive footprint and influence in the healthcare sector.
- Market Positioning: Headquartered in Franklin, Tennessee, as a major healthcare service provider, Community Health Systems aims to enhance patient care quality and market competitiveness through its diverse service offerings.
See More
Company Overview: Community Health Systems, Inc. is a healthcare provider operating hospitals and healthcare facilities across the United States.
Stock Price Adjustment: Barclays has reduced the target price for Community Health Systems' stock from $3.50 to $3.00.
See More
- Tender Offer Overview: Community Health Systems' wholly-owned subsidiary CHS/Community Health Systems, Inc. has initiated a tender offer of up to $600 million to purchase outstanding bonds, aiming to optimize its capital structure and enhance financial flexibility.
- Bond Details: The offer includes 4.750% Senior Secured Notes due 2031 with a tender cap of $350 million and 10.875% Senior Secured Notes due 2032 with a cap of $250 million, reflecting the company's focus on reducing debt costs.
- Early Tender Incentive: Holders who validly tender their notes by May 5, 2026, will receive an early tender payment of $50 per $1,000 of notes, designed to encourage early participation and increase the likelihood of a successful tender offer.
- Offer Timeline and Conditions: The tender offer will expire on May 20, 2026, requiring holders to tender their notes before this date, with purchases conducted based on acceptance priority levels to ensure effective debt management while optimizing capital allocation.
See More
- Performance Decline: Community Health Systems (CYH) reported a wider adjusted loss in Q1, resulting in a 15.5% drop in share price, indicating significant financial pressure under current market conditions.
- Market Reaction: The disappointing earnings have raised investor concerns about the company's future profitability, potentially impacting its competitive position in the healthcare sector.
- Financial Challenges: The increased losses suggest issues with operational efficiency and cost control, indicating a need for the company to implement measures to improve its financial health.
- Strategic Adjustment Necessity: As market demands for healthcare services evolve, Community Health Systems may need to reassess its business strategy to adapt to the changing industry landscape.
See More
- Acquisition Expansion: Community Health Systems announced the acquisition of a majority stake in the Surgical Institute of Alabama, its largest acquisition since 2016, expected to close in Q2, aimed at enhancing surgical capabilities in core markets and improving overall business competitiveness.
- Declining Financial Performance: The first quarter adjusted EBITDA was $309 million, down 17.8% year-over-year, primarily impacted by recent hospital divestitures that resulted in a $50 million EBITDA drag, indicating pressure on the company's profitability.
- Cash Flow Strain: The first quarter operating cash flow was a negative $297 million compared to a positive $120 million in the prior year, largely due to delayed payments related to Medicaid and Medicare accounts receivable, reflecting challenges in liquidity management.
- Outlook Guidance: Despite facing challenges from demand softness and unfavorable payer mix, management maintained the 2026 adjusted EBITDA guidance range of $1.34 billion to $1.49 billion, indicating cautious optimism about future recovery.
See More










